Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis
Open accessAbstract
Optic neuritis is an acute inflammatory condition that is highly associated with multiple sclerosis. Currently, the best predictor of future development of multiple sclerosis is the number of T2 lesions visualized by magnetic resonance imaging. Previous research has found abnormalities in the permeability of the blood-brain barrier in normal-appearing white matter of patients with multiple sclerosis and here, for the first time, we present a study on the capability of blood-brain barrier permeability in predicting conversion from optic neuritis to multiple sclerosis and a direct comparison with cerebrospinal fluid markers of inflammation, cellular trafficking and blood-brain barrier breakdown. To this end, we applied dynamic contrast-enhanced magnetic resonance imaging at 3 T to measure blood-brain barrier permeability in 39 patients with monosymptomatic optic neuritis, all referred for imaging as part of the diagnostic work-up at time of diagnosis. Eighteen healthy controls were included for comparison. Patients had magnetic resonance imaging and lumbar puncture performed within 4 weeks of onset of optic neuritis. Information on multiple sclerosis conversion was acquired from hospital records 2 years after optic neuritis onset. Logistic regression analysis showed that baseline permeability in normal-appearing white matter significantly improved prediction of multiple sclerosis conversion (according to the 2010 revised McDonald diagnostic criteria) within 2 years compared to T2 lesion count alone. There was no correlation between permeability and T2 lesion count. An increase in permeability in normal-appearing white matter of 0.1 ml/100 g/min increased the risk of multiple sclerosis 8.5 times whereas having more than nine T2 lesions increased the risk 52.6 times. Receiver operating characteristic curve analysis of permeability in normal-appearing white matter gave a cut-off of 0.13 ml/100 g/min, which predicted conversion to multiple sclerosis with a sensitivity of 88% and specificity of 72%. We found a significant correlation between permeability and the leucocyte count in cerebrospinal fluid as well as levels of CXCL10 and MMP9 in the cerebrospinal fluid. These findings suggest that blood-brain barrier permeability, as measured by magnetic resonance imaging, may provide novel pathological information as a marker of neuroinflammation related to multiple sclerosis, to some extent reflecting cellular permeability of the blood-brain barrier, whereas T2 lesion count may more reflect the length of the subclinical pre-relapse phase.See Naismith and Cross (doi:10.1093/brain/awv196) for a scientific commentary on this article.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In multiple sclerosis patients, increased blood-brain barrier permeability has been shown by DCE-MRI in the cortex and adjacent white matter, corpus callosum and internal capsule, and thalamic gray matter.
“More recently, an increase in BBB permeability has been shown in MS patients by DCE-MRI in the cortex and adjacent white matter (392), corpus callosum and internal capsule (121-123, 421, 574), as well as thalamic gray matter (123).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [122]
The Imaging methods describe DCE-MRI measurements in periventricular normal-appearing white matter and thalamic grey matter, and the Discussion reports that permeability in both regions predicted conversion from optic neuritis to MS. The paper does not identify the corpus callosum or internal capsule as measured regions. It also says thalamic permeability was not higher in the optic-neuritis group as a whole than in healthy controls, so its finding does not establish a general increase in thalamic permeability among MS patients. (LLM, conf=0.84)
Experimental — accuracy not yet measuredIn multiple sclerosis patients at different stages of the disease, elevated Qalb values, increased MMP-9 activity in CSF and serum, and increased CSF leukocyte count have been shown, all indicative of blood-brain barrier breakdown.
“Elevated Qalb values (355), increased MMP-9 activity in CSF and serum (122, 168), and increased CSF leukocyte count (122), all indicative of BBB breakdown, have been shown in MS patients at different stages of the disease.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [122]
The Results (Table 1; page unavailable) show higher CSF leucocyte counts in optic neuritis patients than in healthy controls, and the Results subsection on CSF biomarkers links leucocyte count and CSF MMP9 concentration to measured BBB permeability. However, this study measured MMP9 concentration in CSF, not MMP9 activity in both CSF and serum, and studied optic neuritis patients followed for MS conversion rather than MS patients at different disease stages. The Qalb claim is cited to a different reference (355), not this paper. (LLM, conf=0.89)
Experimental — accuracy not yet measuredGlobal blood-brain barrier disruption occurs at the onset of optic neuritis in patients who go on to develop multiple sclerosis.
“as suggested by findings of global BBB disruption at the onset of optic neuritis in patients who go on to develop MS (122).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802 · see citing works
New Multiple Sclerosis Phenotypic Classification
LUBLIN, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,260 · see citing works
Barkhof, F. (1997) · Brain · doi:10.1093/brain/120.11.2059 · Cited by 1,251 · see citing works
Scalfari, A., Neuhaus, A., Degenhardt, A., Rice, G. P., Muraro, P. A., Däumer, M., & Ebers, G. C. (2010) · Brain · doi:10.1093/brain/awq118 · Cited by 711 · see citing works
The influence of cytokines on the integrity of the blood-brain barrier in vitro
de Vries, H. E., Blom-Roosemalen, M. C. M., van Oosten, M., de Boer, A. G., van Berkel, T. J. C., Breimer, D. D., & Kuiper, J. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00148-4 · Cited by 666 · see citing works
Miller, D., Barkhof, F., Montalban, X., Thompson, A., & Filippi, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70071-5 · Cited by 594 · see citing works
What is the blood–brain barrier (not)?
Bechmann, I., Galea, I., & Perry, V. H. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.11.007 · Cited by 520 · see citing works
Multiple Sclerosis Risk After Optic Neuritis
The Optic Neuritis Study Group (2008) · Archives of Neurology · doi:10.1001/archneur.65.6.727 · Cited by 476 · see citing works
The Blood-Brain Barrier in Neuroinflammatory Diseases
de Vries, H. E., Kuiper, J., de Boer, A. G., van Berkel, T. J. C., & Breimer, D. D. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01320-6 · Cited by 430 · see citing works
Tintoré, M., Rovira, À., Martinez, M. J., Río, J., Villoslada, P., Brieva, L., Borrás, C., Grivé, E., Capellades, J., & Montalbán, X. (2000) · PubMed Central · Cited by 419 · see citing works
The thalamus and multiple sclerosis
Minagar, A., Barnett, M. H., Benedict, R. H. B., Pelletier, D., Pirko, I., Sahraian, M. A., Frohman, E., & Zivadinov, R. (2013) · Neurology · doi:10.1212/wnl.0b013e31827b910b · Cited by 323 · see citing works
Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
Vercellino, M., Masera, S., Lorenzatti, M., Condello, C., Merola, A., Mattioda, A., Tribolo, A., Capello, E., Mancardi, G., Mutani, R., et al. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181a19a5a · Cited by 292 · see citing works
Khademi, M., Kockum, I. S., Andersson, M., Iacobaeus, E., Brundin, L., Sellebjerg, F. T., Hillert, J. A., Piehl, F., & Olsson, T. P. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510389102 · Cited by 261 · see citing works
Leppert, D. (1998) · Brain · doi:10.1093/brain/121.12.2327 · Cited by 251 · see citing works
Engelhardt, B., & Coisne, C. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-4 · Cited by 248 · see citing works
Larsson, H., Courivaud, F., Rostrup, E., & Hansen, A. E. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22136 · Cited by 236 · see citing works
Self-citationCramer, S. P., Simonsen, H., Frederiksen, J. L., Rostrup, E., & Larsson, H. B. W. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.12.001 · Cited by 232 · cited 10× · see citing works
“We used an axial T2weighted MRI sequence [five slices, echo time = 100 ms, repetition time = 3000 ms, acquired voxel-size 0.57/0.76/8 mm3 (interpolated to 0.45/0.45/8 mm3), field of view = 230 119 mm2] with same orientation and slice thickness (8 mm) as our DCE-MRI sequence, in order to manually…”
BackgroundMethodInfluentialSelf-citationMeningeal and cortical grey matter pathology in multiple sclerosis
Popescu, B. F. G., & Lucchinetti, C. F. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-11 · Cited by 200 · see citing works
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes
Avolio, C., Ruggieri, M., Giuliani, F., Liuzzi, G. M., Leante, R., Riccio, P., Livrea, P., & Trojano, M. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00006-7 · Cited by 176 · see citing works
Sørensen, T. L., Sellebjerg, F. T., Jensen, C. V., Strieter, R. M., & Ransohoff, R. M. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00327.x · Cited by 127 · see citing works
Modvig, S., Degn, M., Roed, H., Sørensen, T., Larsson, H. B. W., Langkilde, A., Frederiksen, J. L., & Sellebjerg, F. T. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515574148 · Cited by 120 · see citing works
Self-citationCramer, S. P., & Larsson, H. B. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.126 · Cited by 117 · see citing works
Self-citationChemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system
Sellebjerg, F. T., & Sørensen, T. L. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00097-2 · Cited by 113 · see citing works
MR properties of rat sciatic nerve following trauma
Stanisz, G. J., Midha, R., Munro, C. A., & Henkelman, R. M. (2001) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200103)45:3 · Cited by 95 · see citing works
Cláudio, L., Kress, Y., Wt, N., & Brosnan, C. F. (1989) · PubMed Central · Cited by 84 · see citing works
Larsson, H., Hansen, A. E., Berg, H., Rostrup, E., & Haraldseth, O. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21328 · Cited by 84 · see citing works
Self-citationClerico, M., Faggiano, F., Palace, J. A., Rice, G. P., Tintoré, M., & Durelli, L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005278.pub3 · Cited by 64 · see citing works
Modvig, S., Degn, M., Horwitz, H., Cramer, S. P., Larsson, H. B. W., Wanscher, B., Sellebjerg, F. T., & Frederiksen, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077163 · Cited by 63 · see citing works
Self-citationRate of Brain Atrophy in Benign vs Early Multiple Sclerosis
Gauthier, S. A., Berger, A. M., Liptak, Z., Duan, Y., Egorova, S., Buckle, G. J., Glanz, B. I., Khoury, S. J., Bakshi, R., Weiner, H. L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.567 · Cited by 51 · see citing works
Hansen, A. E., Pedersen, H., Rostrup, E., & Larsson, H. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22098 · Cited by 50 · see citing works
Self-citationA Spatial Analysis of the Blood—Brain Barrier Damage in Experimental Allergic Encephalomyelitis
Juhler, M., Blasberg, R. G., Fenstermacher, J. D., Patlak, C. S., & Paulson, O. B. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.82 · Cited by 46 · see citing works
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study
D’Alessandro, R., Vignatelli, L., Lugaresi, A., Baldin, E., Granella, F., Tola, M. R., Malagù, S., Motti, L., Neri, W., Galeotti, M., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6838-x · Cited by 37 · see citing works
Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event
Gout, O., Bouchareine, A., Moulignier, A., Deschamps, R., Papeix, C., Gorochov, G., Héran, F., & Bastuji‐Garin, S. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510385506 · Cited by 19 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- van Osch MJ Vonken EJ Bakker CJ Viergever MA Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI. Magn Reson Med 2001; 45: 477– 85. 11241707
Cited by
Sorted by citations
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works
Bridging barriers: a comparative look at the blood–brain barrier across organismsPreprint
O’Brown, N. M., Pfau, S. J., & Gu, C. (2018) · Genes & Development · doi:10.1101/gad.309823.117 · Cited by 261 · see citing works
Bălașa, R., Bărcuţean, L., Mosora, O., & Manu, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168370 · Cited by 160 · see citing works
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
Lovelace, M. D., Varney, B., Sundaram, G., Franco, N. F., Ng, M. L., Pai, S., Lim, C. K., Guillemin, G. J., & Brew, B. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00246 · Cited by 154 · see citing works
Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier
Spencer, J. I., Bell, J. S., & DeLuca, G. C. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316011 · Cited by 152 · see citing works
Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection
Daniels, B. P., Jujjavarapu, H., Durrant, D. M., Williams, J. L., Green, R. R., White, J. P., Lazear, H. M., Gale, M., Diamond, M., & Klein, R. S. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88720 · Cited by 125 · see citing works
Murphy, O. C., Kwakyi, O., Iftikhar, M., Zafar, S., Lambe, J., Pellegrini, N., Sotirchos, E. S., Caldito, N. G., Ogbuokiri, E., Filippatou, A. G., et al. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519845116 · Cited by 113 · see citing works
Wu, Q., Miao, X., Zhang, J., Xiang, L., Li, X., Bao, X., Du, S., Wang, M., Miao, S., Fan, Y., et al. (2021) · Theranostics · doi:10.7150/thno.60031 · Cited by 111 · see citing works
Cai, Y., Zhang, Y., Leng, S., Ma, Y., Jiang, Q., Wen, Q., Ju, S., & Hu, J. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106426 · Cited by 111 · see citing works
Blood–brain barrier and its function during inflammation and autoimmunity
Sonar, S. A., & Lal, G. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ru1117-428r · Cited by 108 · see citing works
Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model
Berghoff, S. A., Düking, T., Spieth, L., Winchenbach, J., Stumpf, S. K., Gerndt, N., Kusch, K., Ruhwedel, T., Möbius, W., & Saher, G. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0497-6 · Cited by 100 · see citing works
Varatharaj, A., Liljeroth, M., Darekar, A., Larsson, H. B. W., Galea, I., & Cramer, S. P. (2018) · The Journal of Physiology · doi:10.1113/jp276887 · Cited by 88 · see citing works
Self-citationIntact blood−brain barrier during spontaneous attacks of migraine without aura: a 3T DCE‐MRI study
Amin, F., Hougaard, A., Cramer, S., Christensen, C., Wolfram, F., Larsson, H., & Ashina, M. (2017) · European Journal of Neurology · doi:10.1111/ene.13341 · Cited by 66 · see citing works
Self-citationThe Role of CXCR3 in Neurological Diseases
Zhou, Y., Liu, D.-Q., Chen, S., Sun, J., Zhou, X.-R., Xing, C., Ye, D., & Tian, Y. (2019) · Current Neuropharmacology · doi:10.2174/1570159x15666171109161140 · Cited by 62 · see citing works
A Comprehensive View on MRI Techniques for Imaging Blood-Brain Barrier Integrity.
Elschot, E. P., Backes, W., Postma, A., van Oostenbrugge, R. V., Staals, J., Rouhl, R., & Jansen, J. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000723 · Cited by 54 · see citing works
How does neurovascular unit dysfunction contribute to multiple sclerosis?
Cashion, J. M., Young, K. M., & Sutherland, B. A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106028 · Cited by 57 · see citing works
Optic neuritis: the eye as a window to the brain
Jenkins, T. M., & Toosy, A. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000414 · Cited by 52 · see citing works
Omega-3 fatty acids are associated with blood-brain barrier integrity in a healthy aging population
Barnes, S., Chowdhury, S., Gatto, N. M., Fraser, G. E., & Lee, G. J. (2021) · Brain and Behavior · doi:10.1002/brb3.2273 · Cited by 47 · see citing works
ABCD1 dysfunction alters white matter microvascular perfusion
Lauer, A., Da, X., Hansen, M. B., Boulouis, G., Ou, Y., Cai, X., Liberato Celso Pedrotti, A., Kalpathy-Cramer, J., Caruso, P., Hayden, D. L., et al. (2017) · Brain · doi:10.1093/brain/awx262 · Cited by 48 · see citing works
Xu, Z., Zeng, W., Sun, J., Chen, W., Zhang, R., Yang, Z., Yao, Z., Wang, L., Song, L., Chen, Y., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.07.017 · Cited by 46 · see citing works
Matute‐Blanch, C., Montalbán, X., & Comabella, M. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00005-8 · Cited by 45 · see citing works
Luo, Y., Yang, H., Wan, Y., Yang, S., Wu, J., Chen, S., Li, Y., Jin, H., He, Q., Zhu, D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04888-5 · Cited by 49 · see citing works
Földes, A., Kádár, K., Kerémi, B., Zsembery, Á., Gyires, K., Zádori, Z., & Varga, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160121115210 · Cited by 40 · see citing works
Imaging markers of multiple sclerosis prognosis
Louapre, C., Bodini, B., Lubetzki, C., Freeman, L. A., & Stankoff, B. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000456 · Cited by 36 · see citing works
CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review
Freeze, W. M., van der Thiel, M., de Bresser, J., Klijn, C. J. M., van Etten, E. S., Jansen, J. F. A., van der Weerd, L., Jacobs, H. I. L., Backes, W. H., & van Veluw, S. J. (2020) · NeuroImage: Clinical · doi:10.1016/j.nicl.2020.102456 · Cited by 33 · see citing works
Larsson, H. B. W., Vestergaard, M. B., Lindberg, U., Iversen, H. K., & Cramer, S. P. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25488 · Cited by 31 · see citing works
Self-citationAssessment of Blood Brain Barrier Leakage with Gadolinium-Enhanced MRI
Ku, M., Waiczies, S., Niendorf, T., & Pohlmann, A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7531-0_23 · Cited by 31 · see citing works
Palhol, J. S. C., Balia, M., Terán, F. S.-R., Labarchède, M., Gontier, É., & Battefeld, A. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00425-4 · Cited by 30 · see citing works
Novel MRI and PET markers of neuroinflammation in multiple sclerosis
Hagens, M. H. J., van Berckel, B. N. M., & Barkhof, F. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000326 · Cited by 29 · see citing works
Macdonald, D. W., Berdoy, M., & Webster, J. P. (2015) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198745501.003.0011 · Cited by 27 · see citing works
Kutryb-Zając, B. A., Kawecka, A., Caratis, F., Urbanowicz, K., Braczko, A., Furihata, T., Karaszewski, B., Smolenski, R. T., & Rutkowska, A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.998023 · Cited by 26 · see citing works
The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders
Bechter, K. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00773 · Cited by 24 · see citing works
Neuroinflammatory mechanisms of hypertension
Winklewski, P. J., Radkowski, M., & Demkow, U. A. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000250 · Cited by 26 · see citing works
Impaired Cerebral Perfusion in Multiple Sclerosis: Relevance of Endothelial Factors
Monti, L., Morbidelli, L., & Rossi, A. (2018) · Biomarker Insights · doi:10.1177/1177271918774800 · Cited by 20 · see citing works
Jing, Y., Ma, R., Chu, Y., Dou, M., Wang, M., Li, X., & Zhu, L. D. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102004 · Cited by 24 · see citing works
McKee, J. B., Cottriall, C. L., Elston, J. S., Epps, S. J., Evangelou, N., Gerry, S., Kennard, C., Kong, Y., Koelewyn, A., Kueker, W., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517742979 · Cited by 24 · see citing works
Ritson, M., Wheeler-Jones, C. P. D., & Stolp, H. B. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578363 · Cited by 23 · see citing works
Colín‐Castelán, D., & Zaina, S. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09486-z · Cited by 19 · see citing works
Meprin β: A novel regulator of blood–brain barrier integrity
Gindorf, M., Storck, S. E., Ohler, A., Scharfenberg, F., Becker-Pauly, C., & Pietrzik, C. U. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20905206 · Cited by 21 · see citing works
Cramer, S., Simonsen, H., Varatharaj, A., Galea, I., Frederiksen, J., & Larsson, H. (2018) · Annals of Neurology · doi:10.1002/ana.25219 · Cited by 18 · see citing works
Self-citationSekyi, M. T., Lauderdale, K., Atkinson, K. C., Golestany, B., Karim, H., Feri, M., Soto, J. S., Diaz, C., Kim, S. H., Cilluffo, M. C., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12930 · Cited by 20 · see citing works
Xu, Y., Ren, Y. L., Li, X., Xu, W., Wang, X., Duan, Y., Liu, Y., Zhang, X., & Tian, D. (2021) · Neurotherapeutics · doi:10.1007/s13311-020-00973-9 · Cited by 19 · see citing works
Liu, J., Song, S., Gu, X., Li, H., & Yu, X. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1121899 · Cited by 18 · see citing works
Hoeks, C., van Puijfelik, F., Koetzier, S. C., Rip, J., Corsten, C. E. A., Wierenga‐Wolf, A. F., Melief, M., Stinissen, P., Smolders, J., Hellings, N., et al. (2023) · European Journal of Immunology · doi:10.1002/eji.202350544 · Cited by 18 · see citing works
Svrčinová, T., Mareš, J., Chrapek, O., Šínová, I., Rybariková, M., Otruba, P., Kaňovský, P., & Šín, M. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13571 · Cited by 17 · see citing works
Restoring brain barriers: an innovative approach for treating neurological disorders
Lemarchant, S., Engelhardt, B., Cicchetti, F., Bix, G. J., Janus, A., Godfrin, Y., Blasco, H., Campbell, M., & Jacquet, A. D. R. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00688-z · Cited by 16 · see citing works
Hypothalamic neuronal-glial crosstalk in metabolic disease
Nguyen, L. T., & Dodd, G. T. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00026-1 · Cited by 18 · see citing works
Hindsholm, A. M., Cramer, S. P., Simonsen, H. J., Frederiksen, J. L., Andersen, F. L., Højgaard, L., Ladefoged, C. N., & Lindberg, U. (2021) · Clinical Neuroradiology · doi:10.1007/s00062-021-01089-z · Cited by 14 · see citing works
Self-citationCramer, S. P., Larsson, H. B. W., Knudsen, M. H., Simonsen, H. J., Vestergaard, M. B., & Lindberg, U. (2022) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28380 · Cited by 13 · see citing works
Self-citationWang, L., Kwakyi, O., Nguyen, J. V., Ogbuokiri, E., Murphy, O. C., Caldito, N. G., Balcer, L. J., Frohman, E. M., Frohman, T. C., Calabresi, P. A., et al. (2018) · Eye and Vision · doi:10.1186/s40662-018-0123-0 · Cited by 15 · see citing works
Knudsen, M. H., Lindberg, U., Frederiksen, J. L., Vestergaard, M. B., Simonsen, H. J., Varatharaj, A., Galea, I., Blinkenberg, M., Sellebjerg, F. T., Larsson, H. B. W., et al. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103891 · Cited by 13 · see citing works
Self-citationCXCR3 contributes to neuropathic pain via ERK activation in the anterior cingulate cortex
Jing, Q., Li, A., Huang, Y., Teng, R.-H., Yang, Y., & Yao, Y.-X. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.104 · Cited by 11 · see citing works
High HbA1c level is correlated with blood-brain barrier disruption in syphilis patients
Wang, F., Ge, H., Su, X., Wang, R., Zeng, J., & Miao, J. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04031-x · Cited by 9 · see citing works
Grzegorski, T., & Losy, J. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0084 · Cited by 8 · see citing works
Cacciaguerra, L., Rocca, M. A., & Filippi, M. (2023) · Korean Journal of Radiology · doi:10.3348/kjr.2023.0360 · Cited by 8 · see citing works
Gadolinium leakage in ocular structures in optic neuritis.
Förster, A., Böhme, J., Groden, C., & Wenz, H. (2019) · Journal of clinical neuroscience · doi:10.1016/j.jocn.2019.05.050 · Cited by 8 · see citing works
Protective Role of Limitrin in Experimental Autoimmune Optic Neuritis
Chun, B. Y., Kim, J.-H., Jung, Y., Choi, Y. S., Kim, G., Yonezawa, T., & Suk, K. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.9.8 · Cited by 7 · see citing works
Varatharaj, A., Jacob, C., Darekar, A., Yuen, B., Cramer, S. P., Larsson, H. B. W., & Galea, I. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00324 · Cited by 6 · see citing works
Self-citationCramer, S., Hamrouni, N., Simonsen, H. J., Vestergaard, M., Varatharaj, A., Galea, I., Lindberg, U., Frederiksen, J., & Larsson, H. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1546236 · Cited by 4 · see citing works
Self-citationCaratis, F., Mruk, I., Konieczna-Wolska, K., Rojek, B., Hałas, M., Czaplewska, P., Karaszewski, B., Furihata, T., & Rutkowska, A. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101045 · Cited by 4 · see citing works
Report on the Myomatrix Conference April 22–24, 2012, University of Nevada, Reno, Nevada, USA
Rutkowski, A., Bönnemann, C. G., Brown, S., Þorsteinsdóttir, S., Dominov, J. A., Rüegg, M. A., Matter, M. L., Guttridge, D. C., Crosbie, R. H., Kardon, G., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.06.353 · Cited by 4 · see citing works
Jiang, H., Delgado, S. R., & Wang, J. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000897 · Cited by 4 · see citing works
Liutkevičienė, R., Glebauskienė, B., Sidaraitė, A., & Jurkutė, N. (2019) · Neuro-Ophthalmology · doi:10.1080/01658107.2019.1608780 · Cited by 3 · see citing works
Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments
Kishore, U., & Shastri, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.98110 · Cited by 3 · see citing works
A Review of Multiple Sclerosis as an Infectious Syndrome
Stratton, C. W. (2016) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000400 · Cited by 2 · see citing works
Kontopodis, E., Karatzanis, I., Vangelis, S., Buffa, F. M., & Kostas Marias, A. (2016) · Computer Graphics International · doi:10.1145/2949035.2949061 · Cited by 2 · see citing works
Kontopodis, E., Manikis, G. C., Nikiforaki, K., Venianaki, M., Kostas Marias, A., Maris, T. G., Karantanas, A. H., & Papadaki, E. Z. (2018) · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...) · doi:10.1109/bhi.2018.8333366 · Cited by 2 · see citing works
Age-related decline in cerebral oxygen consumption in multiple sclerosis
Knudsen, M. H., Vestergaard, M., Lindberg, U., Simonsen, H. J., Frederiksen, J. L., Cramer, S., & Larsson, H. B. W. (2024) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1177/0271678x231224502 · Cited by 2 · see citing works
Self-citationDutta, R. (2020) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001035 · Cited by 2 · see citing works
Gupta, R. K. (2018) · Neurology India · doi:10.4103/0028-3886.232323 · Cited by 2 · see citing works
Expressional prerequisites for targeted drug delivery to the pathological brain
Helgudóttir, S. S. (2021) · doi:10.54337/aau424058297 · Cited by 1 · see citing works
Editorial: Common pathogenic mechanism of cerebrovascular disease and degenerative diseases
Zheng, W., Liang, Y., Fan, D., & He, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1233204 · Cited by 1 · see citing works
Edema de papila como pródromo de varicela en un paciente pediátrico
Carral-Santander, I. E., & Hernández-Ábrego, M. P. (2016) · Revista Mexicana de Oftalmología · doi:10.1016/j.mexoft.2015.12.005
Enhancing our understanding of white matter changes in early multiple sclerosis.
Naismith, R., & Cross, A. (2015) · Brain : a journal of neurology · doi:10.1093/brain/awv196 · Cited by 1 · see citing works
Bildgebender prospektiver Marker für Neuroinflammation
Menge, T. (2015) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-015-1558-7
Diagnostic options in retrobullar neuritis
Svrčinová, T. (2020) · Neurologie pro praxi · doi:10.36290/neu.2020.094
Physical and Physiological Principles of Perfusion and Permeability
Cramer, S. P., Vestergaard, M. B., Lindberg, U., & Larsson, H. B. W. (2020) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-12-817057-1.00013-5
Self-citationPost-stroke dizziness of visual-vestibular cortices origin
Inoue, N., & Goto, S. (2020) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001038
Cholesterol metabolism in mouse models of Multiple Sclerosis
Berghoff, S. A. (2020) · doi:10.53846/goediss-8239
Wang, F., Che, X., Yang, Q.-W., Wang, R., Zeng, J.-Q., Chen, Y., Su, X., & Miao, J. (2022) · Neurology India · doi:10.4103/0028-3886.344667
Innate Immunopathological Mechanisms in Multiple Sclerosis
Shastri, A., Singh, I., & Kishore, U. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110626
Burke, O., Jacobs, J. W., Tormey, C. A., Rinder, H. M., Villalba, C. A. F., Lee, E. S., Campos, J. J. S., Abels, E. A., & Yurtsever, N. (2023) · Laboratory Medicine · doi:10.1093/labmed/lmad107
The blood-brain barrier in multiple sclerosis
Zierfuss, B., Charabati, M., MacVicar, B. A., Zandee, S., & Prat, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-823848-6.00011-7
Sayed, R. F. M., Shafik, A. M., AbdelAziz, D. E., & Roshdy, M. M. S. (2024) · Journal of the Egyptian Ophthalmological Society · doi:10.4103/ejos.ejos_10_24
Acute Myelin Oligodendrocyte Glycoprotein-IgG Optic Neuritis without Optic Nerve Enhancement
Jeyanathan, B., & Micieli, J. A. (2024) · Case Reports in Ophthalmology · doi:10.1159/000542889
Passali, M., Knudsen, M. H., Josefsen, K., Antvorskov, J., Hindsholm, A., Lindberg, U., Frederiksen, J., Larsson, H., & Cramer, S. (2025) · Multiple Sclerosis Journal - Experimental, Translational and Clinical · doi:10.1177/20552173251346979 · Cited by 1 · see citing works
Self-citationAnalysis of optic neuritis risk in patients with allergic diseases
Kim, J., Han, K., Jung, J., Oh, S. Y., Park, K., & Min, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-18088-6
Tireli, E. D., Cramer, S., Lindberg, U., Tireli, D., Vestergaard, M., & Larsson, H. (2026) · bioRxiv · doi:10.64898/2026.02.15.705995
Self-citationMacrophage activation profiles of multiple sclerosis patients
Fransson, J. (2019) · theses.fr (ABES) · doi:10.70675/361929ebz66c2z48dbz83a1z8955d8b54716
larsson, B. W., Zebis, M. K., Vismann, J., Ørner, F. F., Tireli, E. D., Clausen, K. D., Fenger, I., Shacham, D. A., Tireli, D., Haraldsson, B. T., et al. (2026) · JMIR Research Protocols · doi:10.2196/93795
Self-citationHenry-Ojo, H. O., Liu, F., Alanazi, A. H., Zahedi, K. A., Soleimani, M., Zhang, D., Somanath, P. R., & Narayanan, S. P. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.8.4
Zheng, J., Liu, H., Li, Y., Sun, Y., Yang, Z., Zhang, X., Du, Z., Wu, J., Pei, L., Qiu, X., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71503
Tireli, E. D., Cramer, S., Lindberg, U., Tireli, D., Vestergaard, M., & Larsson, H. B. W. (2026) · Magnetic Resonance in Medicine · doi:10.1002/mrm.70554
Self-citation
- Authors
- Cramer, S. P., Modvig, S., Simonsen, H. J., Frederiksen, J. L., & Larsson, H. B. W.
- Affiliations
- Rigshospitalet (DK)
- University of Copenhagen (DK)
- Corresponding author
- Cramer, Stig P.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-07-17
- Volume
- 138
- Issue
- 9
- Pages
- 2571-2583
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC4547053
- OpenAlex
- W1805190614
- Cited by
- 94
- References
- 33
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 8 · 2022: 6 · 2021: 8 · 2020: 12 · 2019: 8 · 2018: 11 · 2017: 9 · 2016: 10 · 2015: 3 · 2012: 1
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Biogen
- Scleroseforeningen (14588)
- Multiple Sclerosis Society (14588)
- Rigshospitalet
- Region Hovedstaden
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- blood-brain barrier permeability, optic neuritis, conversion to multiple sclerosis, normal-appearing white matter, dynamic contrast-enhanced MRI, cerebrospinal fluid biomarkers, CXCL10, MMP-9, white blood cell count, neuroinflammation, disease progression prediction, blood-brain barrier disruption, cell trafficking
- MeSH terms
- Adolescent, Adult, Blood-Brain Barrier, Brain, Capillary Permeability, Female, Humans, Immunoglobulin G, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Optic Neuritis, Predictive Value of Tests, Risk Factors, ROC Curve, Statistics, Nonparametric, Chemokines, Oligoclonal Bands, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review